ConductScience.org, home

Paper42432829

Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.

Man SK and 7 others. Eur J Neurosci, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia. Papers, record 42432829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42432829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.
PubMed
Journal
Eur J Neurosci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-06
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Man SKShue Kithttps://orcid.org/0009-0005-2011-0383
2Blasco MBM Belen
3Alemi RRazieh
4Raminfard SSamira
5Rusjan PMPablo M
6Near JJamie
7Sarpal DKDeepak Khttps://orcid.org/0000-0001-5842-6782
8Mizrahi RRominahttps://orcid.org/0000-0001-6667-7928

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glutamic AcidMajor topic
SchizophreniaMajor topic
Psychotic DisordersMajor topic
BrainMajor topic
Humans
Male
Female
Adult
Young Adult
Proton Magnetic Resonance Spectroscopy
Hippocampus
Adolescent

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
260879Canada Foundation for InnovationPubMed
254592Healthy Brains, Healthy LivesPubMed
Healthy Brains, Healthy Lives (HBHL)PubMed
Canada Foundation for Innovation's (CFI)PubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128503156Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies.Front Psychiatry2017https://conductscience.org/library/papers/28503156PubMed
226117693Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils.Magn Reson Imaging2015https://conductscience.org/library/papers/26117693PubMed
316018980Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.Biol Psychiatry2005https://conductscience.org/library/papers/16018980PubMed
43616518The positive and negative syndrome scale (PANSS) for schizophrenia.Schizophr Bull1987https://conductscience.org/library/papers/3616518PubMed
59355168The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions.Psychiatr Serv1997https://conductscience.org/library/papers/9355168PubMed
629031411In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.Biol Psychiatry2018https://conductscience.org/library/papers/29031411PubMed
736806762Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.Mol Psychiatry2023https://conductscience.org/library/papers/36806762PubMed
826925800Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.Schizophr Res2016https://conductscience.org/library/papers/26925800PubMed
934584230Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.Mol Psychiatry2022https://conductscience.org/library/papers/34584230PubMed
1012955285NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12955285PubMed
1134505389Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls.World Psychiatry2021https://conductscience.org/library/papers/34505389PubMed
1214989408Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.Schizophr Bull2003https://conductscience.org/library/papers/14989408PubMed
1326320195
Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Schizophr Bull2016https://conductscience.org/library/papers/26320195PubMed
1442432829Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.Eur J Neurosci2026https://conductscience.org/library/papers/42432829PubMed
1530427993Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.JAMA Psychiatry2019https://conductscience.org/library/papers/30427993PubMed
1632303767Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study.Schizophr Bull2020https://conductscience.org/library/papers/32303767PubMed
1734259821Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.JAMA Psychiatry2021https://conductscience.org/library/papers/34259821PubMed
1821956446From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.Neuropsychopharmacology2012https://conductscience.org/library/papers/21956446PubMed
1925548816Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra.J Magn Reson Imaging2014https://conductscience.org/library/papers/25548816PubMed
2035396580Mapping genomic loci implicates genes and synaptic biology in schizophrenia.Nature2022https://conductscience.org/library/papers/35396580PubMed

See all 42 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42432829Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.Eur J Neurosci2026https://conductscience.org/library/papers/42432829

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42432829

GET https://conductscience.org/api/papers/v1/42432829/references?page=2